<?xml version="1.0" encoding="UTF-8"?>
<ref id="B40-jcm-10-00375">
 <label>40.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Grzywa</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Klicka</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Rak</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Mehlich</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Garbicz</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Zieliński</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Maksymowicz</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Sajjad</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Włodarski</surname>
    <given-names>P.K.</given-names>
   </name>
  </person-group>
  <article-title>Lineage-dependent role of miR-410-3p as oncomiR in gonadotroph and corticotroph pituitary adenomas or tumor suppressor miR in somatotroph adenomas via MAPK, PTEN/AKT, and STAT3 signaling pathways</article-title>
  <source>Endocrine</source>
  <year>2019</year>
  <volume>65</volume>
  <fpage>646</fpage>
  <lpage>655</lpage>
  <pub-id pub-id-type="doi">10.1007/s12020-019-01960-7</pub-id>
  <pub-id pub-id-type="pmid">31165412</pub-id>
 </element-citation>
</ref>
